ANUHPHR

Anuh Pharma Share Price

 

 

Start SIP in ANUHPHR

Start SIP

Performance

  • Low
  • ₹81
  • High
  • ₹85
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹115
  • Open Price₹85
  • Previous Close₹84
  • Volume52,863
  • 50 DMA₹78.30
  • 100 DMA₹80.93
  • 200 DMA₹85.40

Investment Returns

  • Over 1 Month + 7.79%
  • Over 3 Month + 1.85%
  • Over 6 Month -9.16%
  • Over 1 Year -10.42%

Smart Investing Starts Here Start SIP with Anuh Pharma for Steady Growth!

Invest Now

Anuh Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.9
  • PEG Ratio
  • -1.2
  • Market Cap Cr
  • 832
  • P/B Ratio
  • 2.5
  • Average True Range
  • 3.19
  • EPS
  • 4.17
  • Dividend Yield
  • 1.8
  • MACD Signal
  • 0.18
  • RSI
  • 62.81
  • MFI
  • 56.01

Anuh Pharma Financials

Anuh Pharma Technicals

EMA & SMA

Current Price
₹83.00
-0.6 (-0.72%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹78.14
  • 50 Day
  • ₹78.30
  • 100 Day
  • ₹80.93
  • 200 Day
  • ₹85.40

Resistance and Support

83.09 Pivot Speed
  • R3 87.13
  • R2 85.82
  • R1 84.40
  • S1 81.67
  • S2 80.36
  • S3 78.94

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Anuh Pharma has an operating revenue of Rs. 767.68 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 9% is okay, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Anuh Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-06 Quarterly Results
2025-11-07 Quarterly Results
2025-08-08 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2025-05-23 Audited Results, Dividend & Bonus issue
2025-02-07 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
Date Purpose Remarks
2025-08-15 FINAL Rs.1.50 per share(30%)Final Dividend (RD date revised)
View Anuh Pharma Dividend History Arrow
Date Purpose Remarks
2025-07-15 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 5/-

Anuh Pharma F&O

Anuh Pharma Shareholding Pattern

71.82%
0%
0%
0%
23.74%
4.44%

About Anuh Pharma

  • NSE Symbol
  • ANUHPHR
  • BSE Symbol
  • 506260
  • Joint Managing Director
  • Mr. Ritesh B Shah
  • ISIN
  • INE489G01022

Similar Stocks to Anuh Pharma

Anuh Pharma FAQs

Anuh Pharma share price is ₹83 As on 12 February, 2026 | 04:04

The Market Cap of Anuh Pharma is ₹831.9 Cr As on 12 February, 2026 | 04:04

The P/E ratio of Anuh Pharma is 19.9 As on 12 February, 2026 | 04:04

The PB ratio of Anuh Pharma is 2.5 As on 12 February, 2026 | 04:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23